Literature DB >> 15131404

Intron 4 mutation in APC gene results in splice defect and attenuated FAP phenotype.

Deborah W Neklason1, Cindy H Solomon, Amy L Dalton, Scott K Kuwada, Randall W Burt.   

Abstract

The adenomatous polyposis coli (APC) protein is a tumor suppressor frequently involved in the development of inherited and sporadic colon cancers. Somatic mutations of the APC gene are found in 80% of all colon cancers. Inherited mutations result in familial adenomatous polyposis (FAP) as well as an attenuated form of this syndrome. FAP is characterized by the early age onset of hundreds to thousands of colonic adenomatous polyps and a virtual certainty of colon cancer unless the colon is removed. The attenuated form of FAP (AFAP) is characterized by fewer adenomas, later onset of adenomas and cancer, and a decreased lifetime cancer risk. We report a 37-year-old man with a history of more than 50 colonic adenomatous polyps, located predominately in the right colon. An insertion of a single thymidine between the second and third base pairs of intron 4 of the APC gene was identified (c.531+2_531+3insT). Monoallelic hybrid cells harboring a single copy of human chromosome 5 were generated from patient lymphoblasts. Sequencing of the APC cDNA product from these cells revealed a single RNA transcript with aberrant splicing in the mutant mRNA whereby exon 4 is deleted. The translational reading frame is shifted after codon 140 and a translational stop is generated predicting a truncated protein of 147 amino acids, thus indicating that the intronic mutation is disease causing. The lack of a secondary transcript from the mutant allele suggests that incomplete exon skipping is not the molecular mechanism behind the attenuated phenotype.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15131404     DOI: 10.1023/B:FAME.0000026824.85766.22

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  25 in total

1.  The identical 5' splice-site acceptor mutation in five attenuated APC families from Newfoundland demonstrates a founder effect.

Authors:  L Spirio; J Green; J Robertson; M Robertson; B Otterud; J Sheldon; E Howse; R Green; J Groden; R White; M Leppert
Journal:  Hum Genet       Date:  1999-11       Impact factor: 4.132

2.  Germline mutations in the 3' part of APC exon 15 do not result in truncated proteins and are associated with attenuated adenomatous polyposis coli.

Authors:  R B van der Luijt; P Meera Khan; H F Vasen; C Breukel; C M Tops; R J Scott; R Fodde
Journal:  Hum Genet       Date:  1996-12       Impact factor: 4.132

3.  Genotype-phenotype correlations in attenuated adenomatous polyposis coli.

Authors:  C Soravia; T Berk; L Madlensky; A Mitri; H Cheng; S Gallinger; Z Cohen; B Bapat
Journal:  Am J Hum Genet       Date:  1998-06       Impact factor: 11.025

4.  Attenuated familial adenomatous polyposis (AFAP). A phenotypically and genotypically distinctive variant of FAP.

Authors:  H T Lynch; T Smyrk; T McGinn; S Lanspa; J Cavalieri; J Lynch; S Slominski-Castor; M C Cayouette; I Priluck; M C Luce
Journal:  Cancer       Date:  1995-12-15       Impact factor: 6.860

Review 5.  Attenuated familial adenomatous polyposis: an evolving and poorly understood entity.

Authors:  Gerald S Hernegger; Harvey G Moore; Jose G Guillem
Journal:  Dis Colon Rectum       Date:  2002-01       Impact factor: 4.585

6.  Notable intrafamilial phenotypic variability in a kindred with familial adenomatous polyposis and an APC mutation in exon 9.

Authors:  P Rozen; Z Samuel; R Shomrat; C Legum
Journal:  Gut       Date:  1999-12       Impact factor: 23.059

7.  Whole-gene APC deletions cause classical familial adenomatous polyposis, but not attenuated polyposis or "multiple" colorectal adenomas.

Authors:  O M Sieber; H Lamlum; M D Crabtree; A J Rowan; E Barclay; L Lipton; S Hodgson; H J W Thomas; K Neale; R K S Phillips; S M Farrington; M G Dunlop; H J Mueller; M L Bisgaard; S Bulow; P Fidalgo; C Albuquerque; M I Scarano; W Bodmer; I P M Tomlinson; K Heinimann
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-26       Impact factor: 11.205

8.  Alleles of the APC gene: an attenuated form of familial polyposis.

Authors:  L Spirio; S Olschwang; J Groden; M Robertson; W Samowitz; G Joslyn; L Gelbert; A Thliveris; M Carlson; B Otterud
Journal:  Cell       Date:  1993-12-03       Impact factor: 41.582

9.  Mutation in a splice-donor site of the APC gene in a family with polyposis and late age of colonic cancer death.

Authors:  L Varesco; V Gismondi; S Presciuttini; J Groden; L Spirio; P Sala; C Rossetti; L De Benedetti; A Bafico; A Heouaine
Journal:  Hum Genet       Date:  1994-03       Impact factor: 4.132

10.  Molecular diagnosis of familial adenomatous polyposis.

Authors:  S M Powell; G M Petersen; A J Krush; S Booker; J Jen; F M Giardiello; S R Hamilton; B Vogelstein; K W Kinzler
Journal:  N Engl J Med       Date:  1993-12-30       Impact factor: 91.245

View more
  20 in total

1.  Meta-analysis of gene expression profiles indicates genes in spliceosome pathway are up-regulated in hepatocellular carcinoma (HCC).

Authors:  Weijin Xu; Huixing Huang; Long Yu; Lihuan Cao
Journal:  Med Oncol       Date:  2015-03-03       Impact factor: 3.064

Review 2.  Alternative splicing and disease.

Authors:  Jamal Tazi; Nadia Bakkour; Stefan Stamm
Journal:  Biochim Biophys Acta       Date:  2008-10-17

3.  Identification of 5 novel germline APC mutations and characterization of clinical phenotypes in Japanese patients with classical and attenuated familial adenomatous polyposis.

Authors:  Hong Tao; Kazuya Shinmura; Hidetaka Yamada; Masato Maekawa; Satoshi Osawa; Yasuhiro Takayanagi; Kazuya Okamoto; Tomohiro Terai; Hiroki Mori; Toshio Nakamura; Haruhiko Sugimura
Journal:  BMC Res Notes       Date:  2010-11-16

4.  Motifs within the CA-repeat-rich region of Surfactant Protein B (SFTPB) intron 4 differentially affect mRNA splicing.

Authors:  Wenjun Yang; Lan Ni; Patricia Silveyra; Guirong Wang; Georgios T Noutsios; Anamika Singh; Susan L Diangelo; Olabisi Sanusi; Manmeet Raval; Joanna Floros
Journal:  J Mol Biochem       Date:  2013-02-20

5.  Shared genomic segment analysis: the power to find rare disease variants.

Authors:  Stacey Knight; Ryan P Abo; Haley J Abel; Deborah W Neklason; Therese M Tuohy; Randall W Burt; Alun Thomas; Nicola J Camp
Journal:  Ann Hum Genet       Date:  2012-09-19       Impact factor: 1.670

6.  Novel mutations of the APC gene and genetic consequences of splicing mutations in the Czech FAP families.

Authors:  Lucie Schwarzová; Jitka Štekrová; Martina Florianová; Aleš Novotný; Michaela Schneiderová; Petr Lněnička; Věra Kebrdlová; Jaroslav Kotlas; Kamila Veselá; Milada Kohoutová
Journal:  Fam Cancer       Date:  2013-03       Impact factor: 2.375

Review 7.  Alternative splicing within the Wnt signaling pathway: role in cancer development.

Authors:  B Sumithra; Urmila Saxena; Asim Bikas Das
Journal:  Cell Oncol (Dordr)       Date:  2016-01-13       Impact factor: 6.730

8.  Functional pre- mRNA trans-splicing of coactivator CoAA and corepressor RBM4 during stem/progenitor cell differentiation.

Authors:  Yang S Brooks; Guanghu Wang; Zheqiong Yang; Kimberly K Smith; Erhard Bieberich; Lan Ko
Journal:  J Biol Chem       Date:  2009-05-05       Impact factor: 5.157

9.  Alternative splicing and tumor progression.

Authors:  Claudia Ghigna; Cristina Valacca; Giuseppe Biamonti
Journal:  Curr Genomics       Date:  2008-12       Impact factor: 2.236

10.  New mutations in the PKD1 gene in Czech population with autosomal dominant polycystic kidney disease.

Authors:  Jitka Stekrova; Jana Reiterova; Stanislava Svobodova; Vera Kebrdlova; Petr Lnenicka; Miroslav Merta; Ondrej Viklicky; Milada Kohoutova
Journal:  BMC Med Genet       Date:  2009-08-17       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.